Antiglaucomatic Drugs – Content of Preservatives and the Patient’s Compliance

Czech version

Authors: P. Výborný; L. Sejčková
Authors‘ workplace: Cornea Lexum, ředitelka doc. MUDr. Drahomíra Baráková, CSc. ; Oční oddělení ÚVN – Oční klinika 1. LF UK a ÚVN, Praha přednosta doc. MUDr. Jiří Pašta, CSc.
Published in: Čes. a slov. Oftal., 62, 2006, No. 4, p. 270-274

Overview

The presence of preservatives in eye drops, may have, depending on the concentration, cytotoxic influence on the corneal and conjunctival cells, and may cause the patients’ subjective inconveniences. The authors compare the benzalconium chloride (BAC) concentrations in individual drug used for glaucoma treating. The daily dose of BAC was calculated according to the drop’s size and BAC concentration. The daily dose of BAC differs depending on the selected therapy markedly – doses in the range from 0 to 10 micrograms were found. The BAC concentration is one of important factors affecting the patient’s compliance in the treatment of the primary open angle glaucoma.

Key words:
primary open angle glaucoma, antiglaucomatics, benzalconium chloride

Labels

Ophthalmology

The Effect of Glycine with Timoptol on the Rabbit IOP Physiological Values

TINU Syndrome

The Slovak Study of the Travoprost Treatment Efficacy

Surgical Treatment of Submacular Hemorrhage Combined with Tissue Plasminogen Activator (a Case Report)

Infliximab in the Treatment of Wegener’s Granulomatosis: Case Report

Article was published in

Czech and Slovak Ophthalmology

2006 Issue 4